JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  1999

ACB-CLIN-CHEM-GEN 1999

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: high sensitive estradiol

From:

[log in to unmask]

Reply-To:

[log in to unmask][log in to unmask], 25 Feb 1999 08:35:28 +0000431_iso-8859-1 A GP told me that a patient had shown her a leaflet
about an osteoporosis test sold by a local pharmacy.
This is a urine test sold directly to patients,
and costs about £20.
I think it is a collagen cross-link metabolite assay.

My question are:

What is the positive predictive value for, say,
fracture of the femur?
What is the sensitivity and specificity?
Is the £20 well spent? [...]46_25Feb199908:35:[log in to unmask]

Date:

Fri, 17 Dec 1999 09:48:38 -0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (115 lines)

Hello

The subject of ultra-sensitive oestradiol assays crops up regularly 
and illustrates an interesting 'dilemma' for manufacturers and users 
of assays and their clients.

Without entering into a discussion about the need for oestradiol 
measurements in all the clinical applications listed, if you ask 
clinicians what they require of oestradiol assays they appear to 
want four kinds (a) an ultra low level assay (say 5-100pmol/L) for 
paediatric work,  (b) a low level assay (say 50-250) for peri 
menopausal / infertility work, (c) a normal range assay (say 100-
1000) and (d) a high-level assay (say 1000 - 10,000) for the 
stimulation phase of assisted conception.

Immunoassay theorists and developers will tell you that a single 
assay in 'competitive' limited reagent format cannot cover this 
whole range with adequate imprecision.  The assay has to be 
optimised for part of the range and assay producers have usually 
chosen to emphasise the normal to high levels.  Most 'routine' 
methods in use are not particularly 'sensitive' at low levels 
(<150pmol/L), although people still use them and report results (at 
least to UK NEQAS) well below their 'functional senstivity' (lowest 
result with an imprecision <20% CV).

In an average UK NEQAS distribution of a male oestradiol sample 
(ALTM = 133 pmol/L), one can see huge ranges of results (eg 11 - 
203 pmol/L) for a well-known automated analyser and an absolute 
range for all methods of 11 - 327 pmol/L).  Most clinicalns and 
many labs are unaware of this variability and uncertainty.

In the research field, laboratories have re-optimised traditional 
extraction assays to achieve adequate imprecision at ultra low 
levels (10 pmol/L).

Manufacturers shy away from producing more than one assay for 
'marketing' reasons, even though the bulk of work that most 
endocrinology sections see for oestradiol is < 400 pmol/L.  One 
manufacturer tried to sell a low level version of its RIA kit some 
years ago, but this was not taken up in the UK.  Of course there 
would be practical issues for laboratories in 'guessing' from the 
clincal details on the request as to whether a 'low-level' of 'high-
level' assay should be applied, but clinicians could be educated to 
assist with this.

Most manufacturers of automated systems have been 'ear-bashed' 
by yours truly about this over the years, but only one is known to 
be actively considering the production of two separately optimised 
assays.

In principle, if accurate and precise assays are required at ultra low 
levels for clinical decision making and there is sufficient demand, 
then laboratories must ask manufacturers to provide suitable 
methods.  If two or three separately optimised assays are required 
for oestradiol, so be it.  The marketing and sample sorting 
difficulties will have to be overcome if patient benefit is at stake.

I surveyed participants some years ago as to whether an ultra-low 
level oestradiol UK NEQAS would be helpful.  I received only 10 
expressions of interest, and half of these were non-UK.  This 
number is not really viable for EQA.  Is there a feeling that more 
laboratories want to measure ultra low levels now?

Best wishes to list members for the coming festivities!

Jonathan







Date sent:      	Thu, 16 Dec 1999 08:40:28 +0100
Subject:        	high sensitive estradiol
From:           	"Auch, Dieter" <[log in to unmask]>
To:             	"'Acb-Clin-Chem-Gen (E-Mail)" <[log in to unmask]>
Send reply to:  	"Auch, Dieter" <[log in to unmask]>

> 
> 
> Our endocrinologists request a reportable range of estradiol down to 10
> pmol/L (5pg/ml).
> Our present automated CLIA has a lower limit of 70pmol/L (20pg/ml). The
> reason given is (1.) diagnosis of pubertal development and (2.) (diagnosis
> or managment of) osteoporosis.  
> 
> Is someone measuring E2 down to 10pmol/l and can give some advice (on kit,
> manufacturer and extraction procedure, if necessary? Any help is welcome.
> 
> Regards
> Dieter Auch
> 
> [log in to unmask]
> Dr. med. Dieter Auch
> Inst. f. Klin. Chemie und Pathobiochemie
> Gaffkystr. 11
> D-35392 Gießen
> Tel: +49 641 99 41552
> Fax: +49 641 99 41569
>  
> 


Jonathan Middle PhD
Organiser UK NEQAS for Steroid Hormones
Chairman UK NEQAS Executive
Deputy Director UK NEQAS (Birmingham)
UK NEQAS PO Box 3909 Birmingham B15 3NY
tel 0121 414 7300, fax 0121 414 1179
[log in to unmask]  http://www.ukneqas.org.uk


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager